China NMPA Product Recall - Total Knee System

On January 16, 2023, the National Medical Products Administration (NMPA) announced a voluntary Class III recall initiated by Biomet Orthopedics. This action, reported by Zimmer Medical (Shanghai) International Trading Co., Ltd., targets the Vanguard Total Knee System, registered under Certificate No. 20173130467. The primary reason for this corrective action is the discovery of mixed batches and incorrect labeling pertaining to specific models and production batches of the medical device. This issue could potentially lead to the use of an improperly matched or incorrect part during a surgical procedure, posing a risk to patient safety and the efficacy of the implant. A Class III recall signifies that the product defect is unlikely to cause serious adverse health consequences but may involve a non-serious hazard or a situation where the probability of adverse health consequences is remote. Biomet Orthopedics’ decision to voluntarily recall these products demonstrates a commitment to maintaining product integrity and adhering to stringent quality control standards. Detailed information regarding the precise models, specifications, and affected batches is accessible via the "Medical Device Recall Event Report Form" provided as an attachment to the NMPA's public notice. This action, supervised by the NMPA, reinforces the regulatory framework's role in ensuring the safety and quality of medical devices available in the market.